Study S000490

Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07825857
Acronym: T-STEM
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: NOT_YET_RECRUITING
Enrollment: 228
Start: 2026-10-01
Primary completion: 2031-07-01
Lead sponsor: University of Texas Southwestern Medical Center
Conditions: Methamphetamine Use Disorder
Interventions: DRUG:Tirzepatide; DRUG:Placebo (saline)
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Treatment response [26 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.